Abbott Reaches Agreements To Resolve A Portion Of Litigation Involving Its Specialty Formulas For Preterm Infants
ABT•Abbott reaches agreements on portion of preterm infant formula litigation
Aug. 20 (Reuters) - Abbott Laboratories ABT.N:
- Abbott reaches agreements to resolve a portion of litigation involving its specialty formulas for preterm infants
- Abbott reaches agreements to resolve Gill case and 2,000 related claims
- Abbott to pay about $670 million to resolve Gill case and NEC claims
- Abbott says about 1,700 lawsuits remain pending involving claims for 12,700 infants
- Abbott reaches agreements to resolve a portion of litigation involving its specialty formulas for preterm infants
Source text: ID:nPn5Jcys9a
Further company coverage: ABT.N
